The L-DOPA story revisited. Further surprises to be expected? The contribution of Isamu Sano to the investigation of Parkinson's disease

Journal of Neural Transmission, Supplement

Volumn , Issue 60, 2000, Pages 1-20

  Foley, P ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; IPRONIAZID; LEVODOPA; MONOAMINE OXIDASE INHIBITOR; NORADRENALIN; PHENIPRAZINE; RESERPINE; SEROTONIN;

CONFERENCE PAPER; DOPAMINE RELEASE; DRUG MECHANISM; HISTORY OF MEDICINE; HUMAN; HUMAN CELL; HUMAN TISSUE; NEUROMODULATION; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

ANIMALS; ANTIPARKINSON AGENTS; HISTORY, 20TH CENTURY; HUMANS; JAPAN; LEVODOPA; PARKINSON DISEASE;

EID: 0034520688     PISSN: 03036995     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (63)

1. Demonstration and mapping out of nigro-neostriatal dopamine neurons
2. Miracle cures in Parkinson's disease
3. The riddle of the Parkinson syndrome
4. L-Dopa therapy in Parkinson's disease: A critical review of nine years' experience
5. Excretion of dopamine in diseases of basal ganglia
6. Occurrence and distribution of dopamine in brain and other tissues
7. Der derzeitige Stand der Therapie mit L-Dopa
8. Der L-Dioxyphenylalanin (L-DOPA)-Effekt bei der Parkinson-Akinese
9. Der L-Dioxyphenylalanin (L-DOPA)-Effekt beim Parkinson-Syndrom des Menschen. Zur Pathogenese und Behandlung der Parkinson-Akinese
10. Weitere experimentelle Untersuchungen über L-DOPA beim Parkinson-Syndrom und Reserpin-Parkinsonismus
11. Weitere experimentelle Untersuchungen über den Catecholaminstoffwechsel bei extrapyramidalen Erkrankungen (Parkinson- und Chorea-Syndrom)
12. Summation of the Symposium
13. Interaction of drugs with norepinephrine in the brain
14. The occurrence, distribution and physiological role of catecholamines in the nervous system
15. 3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists
16. On the presence of 3-hydroxytyramine in brain
17. L-Dopa for Parkinsonism
18. Aromatic amino acids and modification of parkinsonism
19. The problem of non-cholinergic transmission in the central nervous system
20. Chemical transmission in the central nervous system
21. Die konservative Therapie der Störungen des extrapyramidalmotorischen Systems
22. 6
23. Parkinson's disease: Symptoms and drug therapy - A discussion
24. Verteilung von Noradrenalin und Dopamin (3-Hydroxytyramin) im Gehirn des Menschen und ihr Verhalten bei Erkrankungen des extrapyramidalen Systems
25. Some electrophysiological and biochemical correlates of motor activity and aggressive behaviour
26. Monoamines in the human neostriatum: Topographic distribution in normals and in Parkinson's disease and their role in akinesia, rigidity, chorea, and tremor
27. Dioxyphenylalanin, eine neue Aminosäure aus Vicia faba
28. Levodopa in the 1960s: Starting point Vienna
29. Changes in carbohydrate metabolism of the mouse brain following the administration of 3,4-dihydroxy-L-phenylalanine
30. Depressive illness
31. Administration of dihydroxyphenylalanine to parkinsonian patients
32. Drug-induced extrapyramidal reactions. Treatment with diphenhydramine hydrochloride and dihydroxyphenylalanine
33. Benadryl in parkinsonism
34. Die Levodopa-Therapie in Japan
35. Parkinson's disease: Distribution of Lewy bodies and monoamine neuron system
36. Parkinson's disease
37. Influence of the substantia nigra on the catecholamine content of the striatum
38. Concentration and distribution of "Encephalin" in the brain of humans and animals
39. An experimental investigation of the connections between the corpus striatum and substantia nigra in the cat
40. [Biochemistry of the extrapyramidal system.] Shinkei Kennkyu no Shinpo
41. Simple peptides in brain
42. L-5-Hydroxytryptophan (L-5-HTP)-Therapie bei endogener Depression
43. L-5-Hydroxytryptophan (L-5-HTP)-Therapie des Morbus Parkinson
44. Amine precursor therapy in psychiatry and neurology
45. Biochemistry of the extrapyramidal system
46. Binding and transport of serotonin in rabbit blood platelets and action of reserpine
47. Active transport of epinephrine into blood platelets
48. Distribution of catechol compounds in human brain
49. Aktiver Transport der aromatischen Monoamine
50. Die Katechinamine im Zentralnervensystem
51. The concept of receptors
52. 3,4-Dimethoxyphenylethylamine and other amines in the urine of schizophrenic patients
53. The concentration of sympathin in different parts of the central nervous system under normal conditions and after administration of drugs
54. Distribution of adrenaline and noradrenaline in the central nervous system and its modification by drugs
55. Changes in the concentration and intracellular distribution of brain catecholamines: The effects of reserpine, βphenylisopropylhydrazine, pyrogallol and 3,4-dihydroxyphenylalanine, alone and in combination
56. Serotonin in mental disorders